AEON AEON Biopharma, Inc.: institutional ownership and insider trading
25 funds reported holding $9.33M of AEON Biopharma, Inc. in their latest 13F filings; in Q2 2026 funds net bought $7.17M, with 2 new positions and 4 funds selling out; over the last 12 months insiders bought $242K and sold $0 on the open market.
Largest institutional holders of AEON
- Dauntless Investment Group, LLC — $8.98M
- VANGUARD GROUP INC — $110K
- GEODE CAPITAL MANAGEMENT, LLC — $68.6K
- VANGUARD CAPITAL MANAGEMENT LLC — $65.1K
- Blue Owl Capital Holdings LP — $30.5K
- Formidable Asset Management, LLC — $19.7K
- StoneX Group Inc. (SNEX) — $14.9K
- VANGUARD FIDUCIARY TRUST CO — $9.86K
- LPL Financial LLC — $8.28K
- CITIGROUP INC (C, C-PN) — $5.26K
Recent AEON insider trades
- Aug 19, 2026: Lynch Timothy P bought 1,150,000 shares ($242K)
- May 21, 2025: Fischer Jost bought 60,000 shares ($29.4K)
- May 20, 2025: Fischer Jost bought 110,000 shares ($55.6K)
5%+ owners
- Timothy P. Lynch: 13.0% (Schedule 13G, filed Aug 21, 2026)
- Stonepine Capital Management, LLC: 9.9% (Schedule 13G, filed Jul 21, 2026)